Related Experiment Video
Updated: Jul 13, 2026

Gastrointestinal Motility Monitor (GIMM)
Published on: December 1, 2010
Gut motility and transit changes in patients receiving long-term methadone maintenance
C S Yuan1, J F Foss, M O'Connor
1Department of Anesthesia and Critical Care, Pritzker School of Medicine, The University of Chicago, Illinois 60637, USA.
Long-term methadone maintenance therapy significantly slows gut transit time in opioid-dependent patients, leading to constipation. This suggests gastrointestinal effects of opioids may not develop tolerance.
Area of Science:
- Gastroenterology
- Pharmacology
- Clinical Research
Background:
- Opioid dependence is a significant public health issue.
- Methadone maintenance therapy is a common treatment for opioid dependence.
- Gastrointestinal side effects, including constipation, are frequently reported by patients on opioid therapy.
Purpose of the Study:
- To investigate gut motility and transit time in opioid-dependent patients undergoing methadone maintenance therapy.
- To quantify oral-cecal transit time (OCTT) in this patient population.
- To assess the prevalence and severity of constipation in patients on long-term methadone.
Main Methods:
- Employed the lactulose hydrogen breath test to measure oral-cecal transit time (OCTT).
- Recruited 19 opioid-dependent volunteers receiving methadone maintenance therapy.
- Collected data on patient-reported constipation symptoms before and during methadone therapy.
Main Results:
- A significant proportion (58%) of patients experienced constipation during methadone therapy.
- Mean OCTT was significantly prolonged (159 ± 49.2 minutes) compared to healthy volunteers (P < 0.01).
- Two patients reported severe constipation, indicating a significant clinical impact.
Conclusions:
- Long-term methadone therapy impairs gastrointestinal motility and transit.
- Tolerance to opioids does not appear to extend to their effects on the gut.
- Patients on methadone maintenance therapy serve as a valuable model for studying opioid-induced gastrointestinal dysfunction and evaluating opioid antagonists.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...

